Zoetis downgraded to Hold from Buy at Stifel
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Agilent Technologies, Merck KGaA, and PerkinElmer Lead with Advanced Analytical and Life Science Solutions
The Environmental Testing Companies Quadrant by MarketsandMarkets 360 offers an in-depth analysis of the global environmental testing market, highlighting over 120 evaluated companies with the Top 15 recognized as quadrant leaders. The market is propelled by stringent regulations, industrialization, and pollution impact awareness, driving demand for advanced testing solutions. Key insights include government-imposed standards for air, water, and soil quality compliance, climate change initiatives, and the rise of IoT and AI technologies. Notable players like Agilent Technologies, Merck KGaA, and PerkinElmer are enhancing their market presence through innovations and strategic partnerships. Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Environmental Testing Products Company Evaluation Report" has been added to Environmental Testing Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Environmental Testing. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. 360 Quadrants evaluated over 120 companies, of which the Top 15 Environmental Testing Companies were categorized and recognized as the quadrant market is experiencing strong growth, driven by stringent environmental regulations, rapid industrialization, and heightened awareness of pollution's health impacts. Governments across the globe are enforcing strict compliance standards for air, water, and soil quality, prompting industries to adopt advanced environmental testing solutions. Additionally, climate change initiatives and sustainability targets are accelerating the demand for real-time monitoring systems, IoT-enabled sensors, and AI-powered analytics. Rising incidents of soil and water contamination, along with the expansion of renewable energy projects and smart city developments, are further boosting market demand. As both industries and governments place greater emphasis on environmental protection, the need for accurate, efficient, and technology-driven testing solutions continues to top criteria for product footprint evaluation included the tested material(microbial contamination, organic compounds, heavy metals, residues, and solids). By sample (wastewater or effluent, soil, air, and others, such as fuel and chemicals). By technology (rapid testing, conventional methods). By end user (agriculture & irrigation sector, government institutes, research and academic institutions, healthcare, industries, and forestry & geology).Key Players:Some of the prominent players are Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Waters Corporation (US), Merck KGaA (Germany), and others. These players are increasingly focusing on product launches and enhancements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, sales contracts, and alliances to strengthen their presence in the global 3 Companies Agilent Technologies, Technologies is a global leader in the life sciences, diagnostics, and applied chemical markets, offering a comprehensive suite of solutions that includes instruments, software, services, and consumables designed to support the entire laboratory workflow. The company operates across three core business segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Within the Life Sciences and Applied Markets segment, Agilent provides advanced instrumentation such as liquid chromatography/mass spectrometry (LC/MS), gas chromatography/mass spectrometry (GC/MS), and inductively coupled plasma mass spectrometry (ICP-MS) - key technologies used in environmental testing and related KGaAMerck KGaA is a global science and technology company involved in the development, production, marketing, and distribution of pharmaceuticals, biopharmaceuticals, specialty chemicals, high-performance materials, and life science tools. In 2015, Merck KGaA significantly expanded its footprint in the life sciences sector through the acquisition of Sigma-Aldrich (US).The company is structured into three main business segments: Healthcare (including Merck Serono, Consumer Health, Allergopharma, and Biosimilars), Performance Materials, and Life Science (operated under the Merck Millipore brand). Within the Life Science segment, Merck Millipore offers cutting-edge solutions for PFAS trace analysis, supporting environmental testing and regulatory compliance. Merck KGaA maintains a strong global presence with operations across Europe, North America, Latin America, Asia Pacific, and Africa. Its major subsidiaries include Merck Serono GmbH, Merck Consumer Health Holding GmbH, Merck Selbstmedikation, Merck Chemicals GmbH, and Merck Schuchardt OHG, all headquartered in is a prominent provider of technologies, services, and solutions catering to the diagnostics, life sciences, environmental, industrial, and laboratory sectors. In March 2023, its Life Science and Diagnostics division was spun off into a separate entity named Revvity, allowing the company to streamline its focus. PerkinElmer operates through two main segments: Discovery & Analytical Solutions and Diagnostics. Within the Discovery & Analytical Solutions segment - specifically under the Applied Markets division - PerkinElmer offers a broad range of mass spectrometry instruments used in environmental analysis and other scientific applications. Its customer base includes pharmaceutical and biotech companies, as well as academic and research Topics Covered: 1 Introduction1.1 Market Definition1.2 Inclusions & Exclusions1.3 Market Stakeholders2 Executive Summary3 Market Overview3.1 Introduction3.2 Market Dynamics3.2.1 Drivers3.2.1.1 Rising Technological Innovations in Environmental Testing3.2.1.2 Growing Public Awareness Related to Health Impact of Pollution3.2.1.3 Development of Portable and Real-Time Environmental Monitoring Technologies3.2.1.4 Increased Participation of Government and Regulatory Bodies in Monitoring Environmental Conditions3.2.2 Restraints3.2.2.1 Expensive Consumables and High Maintenance Cost of Mass Spectrometry Instruments3.2.2.2 Technological Limitations in Mass Spectrometry3.2.3 Opportunities3.2.3.1 Increasing Government Focus on Contaminant Detection3.2.3.2 Increased Utilization of Ai-Driven Analytical Tools to Detect Air and Soil Pollution3.2.3.3 Advancements in Environmental Testing Infrastructure3.2.4 Challenges3.2.4.1 Increased Operational Complexity of Mass Spectrometry Products3.2.4.2 Lack of Skilled Professionals3.3 Trends/Disruptions Impacting Customers' Businesses3.4 Value Chain Analysis3.4.1 Research & Product Development3.4.2 Raw Material Procurement and Manufacturing3.4.3 Distribution and Marketing & Sales3.4.4 Post-Sales Services3.5 Supply Chain Analysis3.5.1 Prominent Companies3.5.2 Small and Medium-Sized Enterprises3.5.3 Distributors3.5.4 End-users3.6 Ecosystem Analysis3.6.1 Role in Ecosystem3.7 Technology Analysis3.7.1 Key Technologies3.7.1.1 Mass Spectrometry (Ms)3.7.1.2 Liquid Chromatography-Mass Spectrometry (Lc-Ms)3.7.1.3 Gas Chromatography-Mass Spectrometry (Gc-Ms)3.7.2 Complementary Technologies3.7.2.1 Laboratory Process Automation3.7.2.2 Cloud Computing3.7.3 Adjacent Technologies3.7.3.1 Environmental Sensors3.8 Patent Analysis3.9 Key Conferences & Events, 2025-20263.10 Porter's Five Force Analysis3.10.1 Bargaining Power of Suppliers3.10.2 Bargaining Power of Buyers3.10.3 Threat of New Entrants3.10.4 Threat of Substitutes3.10.5 Intensity of Competitive Rivalry3.11 Unmet Needs3.12 Impact of Gen Ai/Ai on Environmental Testing Products Market3.12.1 Market Potential of Environmental Testing Products3.12.2 Ai Use Cases3.12.3 Key Companies Implementing Ai3.12.4 Future of Ai in Environmental Testing Products Ecosystem4 Competitive Landscape4.1 Overview4.2 Key Player Strategies/Right to Win4.2.1 Overview of Strategies Adopted by Players in Environmental Testing Products Market4.3 Revenue Analysis, 2019-20234.4 Market Share Analysis, 20234.5 Company Valuation and Financial Metrics4.5.1 Company Valuation4.5.2 Financial Metrics4.6 Brand/Product Comparison4.7 Company Evaluation Matrix: Key Players, 20244.7.1 Stars4.7.2 Emerging Leaders4.7.3 Pervasive Players4.7.4 Participants4.7.5 Company Footprint: Key Players, 20244.7.5.1 Company Footprint4.7.5.2 Region Footprint4.7.5.3 Type Footprint4.7.5.4 Technology Footprint4.7.5.5 Application Footprint4.7.5.6 End-User Footprint4.8 Company Evaluation Matrix: Startups/Smes, 20244.8.1 Progressive Companies4.8.2 Responsive Companies4.8.3 Dynamic Companies4.8.4 Starting Blocks4.8.5 Competitive Benchmarking: Startups/Smes, 20244.8.5.1 Detailed List of Key Startups/Smes4.8.5.2 Competitive Benchmarking of Key Startups/Smes4.9 Competitive Scenario4.9.1 Product Launches4.9.2 Deals4.9.3 Expansions5 Company Profiles Agilent Technologies, Inc. Thermo Fisher Scientific Inc. Waters Corporation Danaher Bruker Shimadzu Corporation Perkinelmer Jeol Ltd. Hitachi High-Tech Corporation Teledyne Technologies Incorporated Ametek, Inc. Jasco Corporation Merck KGaA Leco Corporation Analytik Jena GmbH+Co. Kg Hiden Analytical Rigaku Holdings Corporation Youngin Chromass Scion Instruments Restek Corporation Kore Technology Process Insights, Inc. Masstech Advion, Inc. Skyray Instruments Usa, Inc. Microsaic For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
Yahoo
a day ago
- Yahoo
China pharma firms turn to local reagent suppliers to cut costs and delivery times
By Andrew Silver SHANGHAI (Reuters) -Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers said, as they seek to cut costs and delivery times. Western reagent suppliers including U.S.-based Thermo Fisher Scientific and Germany's Merck have profited in the world's second-largest pharmaceutical market from the compounds used in lab tests for analysis and quality control. But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are spurring Chinese companies to request products from local rivals like Shanghai Titan Scientific and Nanjing Vazyme Biotech instead, the executives and managers said. The five who spoke to Reuters work at Chinese firms involved in the purchase or supply of reagents and their comments are an early sign of an expected industry shift toward more Chinese purchases. China's reagent market for lab and diagnostic use has been to some extent supplied by imports, which were valued at $5.76 billion in 2024, down slightly from $5.83 billion in 2023, according to U.N. Comtrade data. "It is actually more advantageous (for reagents to be local) because the timeliness requirement is high," said Ma Xingquan, co-president of pharmaceutical research firm ChemPartner PharmaTech. Most reagents it uses in its pre-clinical work are products that are made in China by firms including Titan and Shanghai Aladdin Biochemical Technology, he said. ChemPartner's usage of locally made reagents would probably increase further as new products become available, Ma added. TARIFF BUMP The rush to use domestically made reagents has accelerated since April, the month China raised duties on U.S. goods to 125%, a manager at Titan and an executive at Vazyme said, though the levies have since been lowered as Beijing and Washington continue trade talks. Some Chinese drugmakers were worried about tariff policy uncertainty, Titan product manager Yang Dong said. Since April, more than 90% of Vazyme's customers have discussed replacing imported reagents with its products, Vazyme Senior Vice President Xu Xiaoyu said. "Before April, customers were only saying long term, they hope to be able to replace (reagents) with those locally made, it would be better," Xu said. "But to customers these tariffs are like a shock in a short period of time. They clearly felt this type of direct impact... their impetus (for replacement) will be stronger." Titan and Vazyme are both forecast to report strong sales growth this year, according to brokers. China International Capital Corp expects Titan's annual revenue to grow 22% to 3.52 billion yuan ($490.39 million) this year, while Vazyme's revenue is set to rise 15% to 1.59 billion yuan over the same period, according to Soochow Securities. "There is still a lot of room for substitution of imported biological reagent enzymes, clients are strongly interested in locally-made replacements," Soochow said in a recent note. Shares in Titan and Vazyme have risen about 54% and 18% respectively since the start of the year. Merck and Thermo Fisher shares have fallen about 21% and 8% respectively over the same period. CHINA CHALLENGES Morningstar analyst Max Jousma expects China's reagents market to grow more than 10% annually over the next five years, driven by government support for the biotech and pharmaceutical sectors and growth in research and development activity and in-vitro diagnostic testing. Merck and Swiss diagnostics group Roche Holding are moving some of their reagent production closer to their Chinese customers. In 2023, Merck announced plans to invest 70 million euros ($81.35 million) in a reagents facility in Nantong that is on track to begin operations next year. Merck declined to comment on any short-term shifts in ordering patterns from Chinese customers. "The decision to invest in reagent manufacturing in Nantong reflects our commitment to supporting the growing needs of life science and biopharma customers in China and the broader Asia-Pacific region," it said in a statement. Roche is expanding production, laboratory and logistics facilities from 2028 in Suzhou, where it produces reagents for diagnostic systems, the company said in a statement. The expansion will help it meet increasing demand for diagnostic solutions in China and parts of Asia-Pacific, it said. Thermo Fisher declined to comment on its reagent sales and strategy to compete against local manufacturers in China, citing a policy of not providing details of its business by product line or country. Chinese drugmakers that use reagents from Western companies and are looking to purchase substitutes from local firms will face some challenges given the products are difficult to switch during or after the regulatory approval process because of a need for material consistency, industry experts said. "Switching reagents will cause significant disruption and delay for drug development," said Huang Linfeng, a scientist specialising in RNA biology at Duke Kunshan University. Another hurdle is manufacturer access to technology or processes, some of which could still be protected under patent or not disclosed, said Cheng Shaojun, a vice-general manager at supplier Fu Chen (Tianjin) Chemical Reagents Co. "(Reagent) production equipment is also not necessarily able to be bought," he added. ($1 = 0.8605 euros) ($1 = 7.1779 Chinese yuan renminbi)
Yahoo
a day ago
- Yahoo
Stifel Affirms ‘Buy' Rating on Lam Research (LRCX) on Higher China Wafer Demand
Lam Research Corporation (NASDAQ:LRCX) is one of the top tech stocks with a strong return on equity. On July 31, analysts at Stifel reiterated a 'Buy' rating on the semiconductor equipment maker and raised the price target to $115 from $110. Dragon Images/ The stock price target hikes follow Lam Research delivering impressive quarterly results that exceed consensus estimates on revenues and earnings. The solid results were driven by record foundry segment results, backed by strong demand from China and increased NAND upgrades. Stifel expects the strong momentum from Lam Research's results to continue into the second half of the year. The research firm is projecting higher quarter-over-quarter revenue supported by higher China wafer fabrication equipment spending. Likewise, the research firm expects the company's revenue to grow by approximately 30% this year, with systems revenue increasing at a significantly higher rate. Lam Research Corporation (NASDAQ:LRCX) is a technology company that designs, manufactures, and services semiconductor processing equipment used in the fabrication of integrated circuits. It focuses on wafer fabrication, providing tools and services for chipmakers to produce smaller, faster, and more efficient electronic devices. While we acknowledge the potential of LRCX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best NYSE Penny Stocks to Invest in Now and 10 Best 52-Week High Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
